China Universal Asset Management Co., Ltd. Inovio Pharmaceuticals, Inc. Transaction History

China Universal Asset Management Co., Ltd.

$893 Million
Q3 2024

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 May 21, 2024	BUY	$0.38 - $0.58 $1,307 - $1,995	3,441 Added 99.91%	6,885 $2,000
Q3 2023 Oct 30, 2023	BUY	$0.38 - $0.58 $1,307 - $1,995	3,441 Added 99.91%	6,885 $3,000
Q2 2023 May 21, 2024	BUY	$0.39 - $0.94 $24 - $60	64 Added 1.89%	3,444 $1,000
Q2 2023 Jul 27, 2023	BUY	$0.39 - $0.94 $24 - $60	64 Added 1.89%	3,444 $2,000
Q1 2023 May 21, 2024	BUY	$0.79 - $1.91 $667 - $1,613	845 Added 33.33%	3,380 $2,000
Q1 2023 Apr 27, 2023	BUY	$0.79 - $1.91 $667 - $1,613	845 Added 33.33%	3,380 $3,000
Q4 2022 May 21, 2024	BUY	$1.41 - $2.5 $3,574 - $6,337	2,535 New	2,535 $3,000
Q4 2022 Jan 31, 2023	BUY	$1.41 - $2.5 $280 - $497	199 Added 8.52%	2,535 $4,000
Q3 2022 Oct 21, 2022	BUY	$1.66 - $2.79 $3,877 - $6,517	2,336 New	2,336 $4,000

Others Institutions Holding INO

# of Institutions

Shares Held

281K

Call Options Held

Put Options Held

View Full List

About INOVIO PHARMACEUTICALS, INC.

Ticker INO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 249,400,000
Market Cap $459M
Description
Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. Its DNA medicines platform uses precisely designed SynCon that identify and optimize the DNA se...

More about INO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of China Universal Asset Management Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on China Universal Asset Management Co., Ltd. with notifications on news.

Account